Genestra brand AFA-gen capsule 15 mg Niacin/ capsule 300 mg Blue… — Class II food recall F-1756-2018
Terminated recall by Seroyal International, a division of Atrium Innovations, reported 2018-08-15, distributed nationwide. Microcystins level found to be above the specification limit of NMT1 ppm as per Raw Material Specification.
| Recall number | F-1756-2018 |
|---|---|
| Product type | Food |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Seroyal International, a division of Atrium Innovations, Richmond Hill, Ontario, Canada |
| Recall initiated | 2018-07-27 |
| Classified | 2018-08-06 |
| Reported by FDA | 2018-08-15 |
| Terminated | 2020-11-25 |
| Distributed | Nationwide (US) |
| Countries outside the US | CA |
| Lot numbers | 6E436-0 |
| Expiration dates | 2018-09 |
Product
Genestra brand AFA-gen capsule 15 mg Niacin/ capsule 300 mg Blue Green Algae / capsule 2 capsules, twice daily Dietary supplement 90 capsules, White 150cc HDPE Bottle with Desiccant and white cap, packed as 12 bottles / shipper case
Reason for recall
Microcystins level found to be above the specification limit of NMT1 ppm as per Raw Material Specification.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/F-1756-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.